Literature DB >> 17601670

A different and safe method of split thickness skin graft fixation: medical honey application.

Ilteris Murat Emsen1.   

Abstract

Honey has been used for medicinal purposes since ancient times. Its antibacterial effects have been established during the past few decades. Still, modern medical practitioners hesitate to apply honey for local treatment of wounds. This may be because of the expected messiness of such local application. Hence, if honey is to be used for medicinal purposes, it has to meet certain criteria. The authors evaluated its use for the split thickness skin graft fixation because of its adhesive and other beneficial effects in 11 patients. No complications such as graft loss, infection, and graft rejection were seen. Based on these results, the authors advised honey as a new agent for split thickness skin graft fixation. In recent years there has been a renewed interest in honey wound management. There are a range of regulated wound care products that contain honey available on the Drug Tariff. This article addresses key issues associated with the use of honey, outlining how it may be best used, in which methods of split thickness skin graft fixations it may be used, and what clinical outcomes may be anticipated. For this reason, 11 patients who underwent different diagnosis were included in this study. In all the patients same medical honey was used for the fixation of the skin graft. No graft loss was seen during both the first dressing and the last view of the grafted areas. As a result, it has been shown that honey is also a very effective agent for split thickness skin graft fixations. Because it is a natural agent, it can be easily used in all skin graft operation for the fixation of the split thickness skin grafts.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17601670     DOI: 10.1016/j.burns.2006.12.005

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  12 in total

1.  Comparison between topical honey and mafenide acetate in treatment of burn wounds.

Authors:  H Maghsoudi; F Salehi; M K Khosrowshahi; M Baghaei; M Nasirzadeh; R Shams
Journal:  Ann Burns Fire Disasters       Date:  2011-09-30

2.  Simplified negative pressure wound therapy in pediatric hand wounds.

Authors:  Rahul Kasukurthi; Gregory H Borschel
Journal:  Hand (N Y)       Date:  2009-06-27

3.  The unusual antibacterial activity of medical-grade Leptospermum honey: antibacterial spectrum, resistance and transcriptome analysis.

Authors:  S E Blair; N N Cokcetin; E J Harry; D A Carter
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-06-10       Impact factor: 3.267

Review 4.  Up-to-date use of honey for burns treatment.

Authors:  A Zbuchea
Journal:  Ann Burns Fire Disasters       Date:  2014-03-31

5.  Zero flow global ischemia-induced injuries in rat heart are attenuated by natural honey.

Authors:  Moslem Najafi; Fahimeh Zahednezhad; Mehrban Samadzadeh; Haleh Vaez
Journal:  Adv Pharm Bull       Date:  2012-06-25

6.  Porcine Fibrin Sealant Promotes Skin Wound Healing in Rats.

Authors:  Lihuo Zhang; Lu Liu; Jundong Zhang; Ping Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-23       Impact factor: 2.650

7.  Traditional and modern uses of natural honey in human diseases: a review.

Authors:  Tahereh Eteraf-Oskouei; Moslem Najafi
Journal:  Iran J Basic Med Sci       Date:  2013-06       Impact factor: 2.699

8.  Role of honey (Madhu) in the management of wounds (Dushta Vrana).

Authors:  Tukaram S Dudhamal; S K Gupta; C Bhuyan
Journal:  Int J Ayurveda Res       Date:  2010-10

9.  Acute administration of natural honey protects isolated heart in normothermic ischemia.

Authors:  Afshin Gharekhani; Moslem Najafi; Hamed Ghavimi
Journal:  Iran J Pharm Res       Date:  2012       Impact factor: 1.696

10.  Evaluation of histomorphometric changes in tissue architecture due to fixation delay.

Authors:  Pallav Singhal; Gadiputi Sreedhar; Narendra Nath Singh; Divya Sharma; Sumita Bannerji; Owais Gowhar
Journal:  J Oral Maxillofac Pathol       Date:  2017 Jan-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.